Organization
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
27 clinical trials
1 abstract
Abstract
ARTEMIS-002: Phase 2 study of HS-20093 in patients with relapsed or refractory osteosarcoma.Org: Musculoskeletal Tumor Center, Peking University People's Hospital, Tianjin Medical University Cancer Institute and Hospital, Department of Musculoskeletal Oncology, the First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital,
Clinical trial
Clinical Study on the Safety and Efficacy of QY-1-T in the Treatment of HBV-associated Advanced Liver CancerStatus: Recruiting, Estimated PCD: 2025-01-30
Clinical trial
Clinical Study of Multi-mode Thermal Ablation for the Treatment of Pancreatic Cancer With Liver MetastasisStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
An Exploratory Clinical Trial Evaluating LX109 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD)Status: Not yet recruiting, Estimated PCD: 2025-09-30
Clinical trial
The Safety and Clinical Efficacy of Human CD19/CD22 Bispecific Chimeric Antigen Receptor (CAR)-T Cell Therapy for Subjects With Measurable Residual Disease(MRD)-Positive B Cell Acute Lymphoblastic LeukemiaStatus: Completed, Estimated PCD: 2023-11-01
Clinical trial
The Safety and Clinical Efficacy of Human CD7 CAR-T Cell Therapy for Patients With Relapsed/Refractory CD7 Positive T Cell Hematological MaliganaciesStatus: Recruiting, Estimated PCD: 2024-08-01
Clinical trial
A Single-arm, Single-center, Prospective Phase I/II Study of Fuquinitinib Combined With Capecitabine First-line Maintenance in the Treatment of Metastatic Colorectal CancerStatus: Not yet recruiting, Estimated PCD: 2026-12-15
Clinical trial
The Value of Tumor Feeding Vessels Deprivation Combined With Tyrosine Kinase Inhibitor in Liver TransplantationStatus: Completed, Estimated PCD: 2023-12-31
Clinical trial
SHR0302 and Prednisone as First Line Therapy for Chronic Graft Versus Host Disease Following Allogeneic Stem Cell TransplantationStatus: Recruiting, Estimated PCD: 2024-07-01
Clinical trial
The Safety and Clinical Efficacy of Human TRBC1 CAR-T Cell Therapy for Patients With Relapsed/Refractory TRBC1 Positive T Cell Hematological MaliganaciesStatus: , Estimated PCD: 2023-11-26
Clinical trial
An Expanded Clinical Study Evaluating the AAV2-RPE65 Gene Therapy (LX101) in Patients With Leber's Congenital Amaurosis (LCA)Status: Not yet recruiting, Estimated PCD: 2028-09-30
Clinical trial
Shanghai General Hospital Affiliated to Shanghai Jiao Tong UniversityStatus: Completed, Estimated PCD: 2023-08-23
Clinical trial
Fecal Microbiota Transplantation for the Treatment of Steroid Resistant/Dependent Acute Gastrointestinal Graft Versus Host DiseaseStatus: Completed, Estimated PCD: 2024-03-30
Clinical trial
A Single Arm, Phase 2 Study Evaluating Safety and Efficacy of Maintenance Therapy With Hypomethylating Agent and Venetoclax After Allogeneic Stem Cell Transplantation in Patients With f High-risk Myeloid Malignancies.Status: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
A Multicenter, One-arm Phase II Clinical Study of Utidelone Injection Combined With Gemcitabine in First-line Chemotherapy for Unresectable Advanced Pancreatic CancerStatus: Recruiting, Estimated PCD: 2024-07-08
Clinical trial
Technetium-99m Labeled Anti-HER2 sdAb (99m-Tc-NM-02) for HER2 Expression Detection in Breast CancerStatus: Completed, Estimated PCD: 2021-12-31
Clinical trial
The Efficacy and Safety of Venetoclax Plus IM2 Regimen for Relapsed and Refractory T Lymphoblastic Lymphoma/LeukemiaStatus: Recruiting, Estimated PCD: 2024-10-10
Clinical trial
The Efficacy of Immunosuppressive Therapy Combined With Cord Blood Transfusion in Treatment of Severe Aplastic AnemiaStatus: Completed, Estimated PCD: 2021-12-01
Clinical trial
Technetium-99m/Rhenium-188 Labeled Anti-HER2 Single Domain Antibody (99mTc/188Re-NM-02) for HER2 Expression Detection and Radionuclide Therapy in Breast CancerStatus: Recruiting, Estimated PCD: 2024-03-08
Clinical trial
A Single-arm, Open-label, Multicenter Phase 2 Study to Evaluate XELOX + Tislelizumab in Combination With Doxorubicin Hydrochloride Liposome Injection （XELOX+PD-1+PLD）as Neoadjuvant Therapy for Resectable Gastric CancerStatus: Recruiting, Estimated PCD: 2023-09-30
Clinical trial
Safety and Efficacy of an Autologous Tumor Infiltrating Lymphocyte (TIL) Therapy in Patients With Advanced Solid TumorsStatus: Not yet recruiting, Estimated PCD: 2026-02-15
Clinical trial
An Open Label Dose Escalation Clinical Trial to Evaluate the Safety and the Efficacy of LX102-C01 in Patients With Neovascular Age-Related Macular Degeneration (nAMD)Status: Active (not recruiting), Estimated PCD: 2023-06-01
Clinical trial
The Safety and Efficacy for Anti-human CLL-1 CAR-NK Cells in Subjects With Relapsed/Refractory Acute Myeloid LeukemiaStatus: Recruiting, Estimated PCD: 2026-03-15
Clinical trial
Cytomegalovirus Specific Cytotoxic T Lymphocyte for the Treatment of Cytomegalovirus Infection After Allogeneic Hematopoietic Stem Cell TransplantationStatus: Completed, Estimated PCD: 2021-12-31
Clinical trial
Gallium-68 Labelled THP-PSMA for the Clinical Stage and Restage of Prostate Cancer PatientsStatus: Completed, Estimated PCD: 2023-03-31
Clinical trial
The Safety and Clinical Efficacy of Dasatinib Plus Human CD19/CD22 Bispecific CAR-T Cell Therapy for Elderly Subjects With Ph-positive Acute Lymphoblastic LeukemiaStatus: Recruiting, Estimated PCD: 2025-03-01
Clinical trial
An Open Label Dose Escalation Clinical Trial to Evaluate the Safety and the Efficacy of LX103 in Patients With X-Linked Retinoschisis (XLRS)Status: Recruiting, Estimated PCD: 2024-08-01
Clinical trial
Efficacy and Safety of Venetoclax and Azacitidine Combined With Low-Intensity Homoharringtonine Chemotherapy Followed by Allogeneic Hematopoietic Stem Cell Transplantation in Intermediate/High-Risk Newly Diagnosed Acute Myeloid LeukemiaStatus: Recruiting, Estimated PCD: 2026-07-01